Volume 9 Issue 2 (March - April) 2023

Original Articles

A case report of paranoid schizophrenia having symptomatic hyperprolactinemia with aripiprazole
Ardaaspreet Singh Sandhu, Mantaz Kaur Dhillon, Guryodh Singh Sidhu

Hyperprolactinemia is often associated with first generation antipsychotics due to blockade of D2 receptors. Dopamine inhibits prolactin releae by stimulating D2 receptors and serotonin induces prolactin release by 5HT-2A receptors. Here; we present the case of a 28 years old female with paranoid schizophrenia who developed symptomatic hyperprolactinemia with aripiprazole.

 
Html View | Download PDF | Current Issue